Study assesses links between early negative life events, orbitofrontal cortical thickness and depression in young adults

Study found that early negative life events predict depressive symptoms in young adulthood, but not through accelerated thinning of the orbitofrontal cortex (OFC) across adolescence, challenging previous assumptions about the brain’s structural changes and mental health.

XOMA to buy Kinnate; A pain biotech’s small IPO

Plus, news about Blueprint Medicines, Sosei Group and Poxel: XOMA to buy Kinnate Biopharma: The biotech royalty aggregator said it would pay $2.33 per share

February 17, 2024

As J&J’s oral IL-23 takes on Sotyktu, one-year follow-up data show durability: #AAD24

Johnson & Johnson unveiled long-term extension data on Saturday for a program it hopes can compete with Bristol Myers Squibb’s Sotyktu in plaque psoriasis. Results

March 10, 2024

Pharmalittle: We’re reading about the end of a Lilly drug shortage, a Novo obesity trial disappointment, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.